Read More Pharma Industry News Kyowa Kirin secures extended EC approval for CRYSVITA in X-linked hypophosphataemia treatment Kyowa Kirin has recently received expanded approval from the European Commission (EC) for its recombinant monoclonal antibody treatment,… bypharmanewsdailyOctober 4, 2020
